These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22699492)

  • 21. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
    Adak S; DeAndrade D; Pike LJ
    J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.
    Nagy P; Claus J; Jovin TM; Arndt-Jovin DJ
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16524-9. PubMed ID: 20813958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
    Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
    Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of activation and inhibition of the HER4/ErbB4 kinase.
    Qiu C; Tarrant MK; Choi SH; Sathyamurthy A; Bose R; Banjade S; Pal A; Bornmann WG; Lemmon MA; Cole PA; Leahy DJ
    Structure; 2008 Mar; 16(3):460-7. PubMed ID: 18334220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
    Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX
    Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
    Mendrola JM; Berger MB; King MC; Lemmon MA
    J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR oligomerization organizes kinase-active dimers into competent signalling platforms.
    Needham SR; Roberts SK; Arkhipov A; Mysore VP; Tynan CJ; Zanetti-Domingues LC; Kim ET; Losasso V; Korovesis D; Hirsch M; Rolfe DJ; Clarke DT; Winn MD; Lajevardipour A; Clayton AH; Pike LJ; Perani M; Parker PJ; Shan Y; Shaw DE; Martin-Fernandez ML
    Nat Commun; 2016 Oct; 7():13307. PubMed ID: 27796308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site.
    Arteaga CL; Ramsey TT; Shawver LK; Guyer CA
    J Biol Chem; 1997 Sep; 272(37):23247-54. PubMed ID: 9287333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
    Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
    Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
    Arkhipov A; Shan Y; Kim ET; Shaw DE
    PLoS Comput Biol; 2014 Jul; 10(7):e1003742. PubMed ID: 25058506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands.
    Jin P; Zhang J; Beryt M; Turin L; Brdlik C; Feng Y; Bai X; Liu J; Jorgensen B; Shepard HM
    Mol Med; 2009; 15(1-2):11-20. PubMed ID: 19048033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation - molecular dynamics study.
    Motamedi Z; Rajabi-Maham H; Azimzadeh Irani M
    J Mol Model; 2021 Nov; 27(12):361. PubMed ID: 34817689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
    Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bivalence of EGF-like ligands drives the ErbB signaling network.
    Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
    EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
    Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
    Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
    Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
    J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation.
    Trenker R; Diwanji D; Bingham T; Verba KA; Jura N
    Elife; 2024 Mar; 12():. PubMed ID: 38498590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.